Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

ImmuneSense Lyme Study

ClinicalTrials.gov ID: NCT04422314

Public ClinicalTrials.gov record NCT04422314. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 4:44 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT04422314
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Adaptive Biotechnologies
Industry
Enrollment
893 participants

Conditions and interventions

Conditions

Interventions

  • T-Detect Lyme Diagnostic Test

Diagnostic Test

Eligibility (public fields only)

Age range
7 Years and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 8, 2020
Primary completion
Oct 28, 2021
Completion
Oct 29, 2021
Last update posted
Apr 14, 2022

2020 – 2021

United States locations

U.S. sites
34
U.S. states
14
U.S. cities
32
Facility City State ZIP Site status
Adaptive Biotechnologies Investigational Site Danbury Connecticut 06810
Adaptive Biotechnologies Investigational Site Macon Georgia 31210
Adaptive Biotechnologies Investigational Site Savannah Georgia 31406
Adaptive Biotechnologies Investigational Site Baton Rouge Louisiana 70806
Adaptive Biotechnologies Investigational Site Lewiston Maine 04240
Adaptive Biotechnologies Investigational Site Elkridge Maryland 21075
Adaptive Biotechnologies Investigational Site Rockville Maryland 20854
Adaptive Biotechnologies Investigational Site Towson Maryland 21204
Adaptive Biotechnologies Investigational Site Beverly Massachusetts 01915
Adaptive Biotechnologies Investigational Site Methuen Massachusetts 01844
Adaptive Biotechnologies Investigational Site Springfield Massachusetts 01101
Adaptive Biotechnologies Investigational Site Freehold New Jersey 07728
Adaptive Biotechnologies Investigational Site Binghamton New York 13901
Adaptive Biotechnologies Investigational Site Endwell New York 13760
Adaptive Biotechnologies Investigational Site New Windsor New York 12553
Adaptive Biotechnologies Investigational Site Syracuse New York 13210
Adaptive Biotechnologies Investigational Site Altoona Pennsylvania 16601
Adaptive Biotechnologies Investigational Site Altoona Pennsylvania 16801
Adaptive Biotechnologies Investigational Site Hatboro Pennsylvania 19040
Adaptive Biotechnologies Investigational Site Pittsburgh Pennsylvania 15236
Adaptive Biotechnologies Investigational Site Pittsburgh Pennsylvania 15243
Adaptive Biotechnologies Investigational Site Scottdale Pennsylvania 15683
Adaptive Biotechnologies Investigational Site Smithfield Pennsylvania 15478
Adaptive Biotechnologies Investigational Site Tipton Pennsylvania 16684
Adaptive Biotechnologies Investigational Site Uniontown Pennsylvania 15401
Adaptive Biotechnologies Investigational Site Warwick Rhode Island 02886
Adaptive Biotechnologies Investigational Site Dakota Dunes South Dakota 57049
Adaptive Biotechnologies Investigational Site Rapid City South Dakota 57702
Adaptive Biotechnologies Investigational Site Burke Virginia 22015
Adaptive Biotechnologies Investigational Site Danville Virginia 24541
Adaptive Biotechnologies Investigational Site Norfolk Virginia 23502
Adaptive Biotechnologies Investigational Site Kingwood West Virginia 26537
Adaptive Biotechnologies Investigational Site Morgantown West Virginia 26501
Adaptive Biotechnologies Investigational Site Wauwatosa Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04422314, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 14, 2022 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04422314 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →